Flagship Harbor Advisors LLC Acquires Shares of 14,820 Astera Labs, Inc. $ALAB

Key Points

• Flagship Harbor Advisors LLC initiated a new position in Astera Labs (NASDAQ:ALAB), acquiring 14,820 shares worth approximately $2.465 million during the fourth quarter.
• Astera Labs topped expectations in the latest quarter with $0.58 EPS vs. $0.51 consensus and $270.58M revenue (up 91.8% YoY), and set Q1 2026 guidance of $0.530–$0.540 EPS.
• Significant insider selling occurred last quarter—577,292 shares worth $69.5M were sold (including Manuel Alba’s 183,000-share sale)—while institutions own 60.47% of the stock and insiders hold 12.50%.

Flagship Harbor Advisors LLC bought a new position in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 14,820 shares of the company's stock, valued at approximately $2,465,000.

Other large investors have also made changes to their positions in the company. Newbridge Financial Services Group Inc. boosted its position in shares of Astera Labs by 14.6% in the fourth quarter. Newbridge Financial Services Group Inc. now owns 7,715 shares of the company's stock worth $1,283,000 after buying an additional 985 shares during the period. Sound Income Strategies LLC increased its holdings in shares of Astera Labs by 9.2% in the 4th quarter. Sound Income Strategies LLC now owns 902 shares of the company's stock valued at $164,000 after purchasing an additional 76 shares during the period. Capricorn Fund Managers Ltd purchased a new stake in shares of Astera Labs in the fourth quarter worth approximately $8,318,000. Trueblood Wealth Management LLC acquired a new stake in shares of Astera Labs during the fourth quarter worth approximately $208,000. Finally, Stratos Wealth Partners LTD. grew its position in Astera Labs by 20.1% during the fourth quarter. Stratos Wealth Partners LTD. now owns 24,565 shares of the company's stock valued at $4,087,000 after purchasing an additional 4,104 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company's stock.

Astera Labs Stock Performance

ALAB opened at $118.99 on Wednesday. Astera Labs, Inc. has a twelve month low of $52.00 and a twelve month high of $262.90. The firm has a market cap of $20.38 billion, a P/E ratio of 97.53, a price-to-earnings-growth ratio of 2.31 and a beta of 1.78. The business has a 50 day moving average price of $129.61 and a 200 day moving average price of $156.62.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping analysts' consensus estimates of $0.51 by $0.07. The business had revenue of $270.58 million for the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The firm's revenue for the quarter was up 91.8% on a year-over-year basis. During the same period in the previous year, the company posted $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Insider Transactions at Astera Labs

In other news, Director Jack R. Lazar sold 2,500 shares of the business's stock in a transaction dated Monday, March 16th. The shares were sold at an average price of $130.00, for a total transaction of $325,000.00. Following the transaction, the director owned 84,851 shares in the company, valued at approximately $11,030,630. The trade was a 2.86% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Manuel Alba sold 183,000 shares of the business's stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total value of $19,692,630.00. Following the transaction, the director owned 319,863 shares in the company, valued at $34,420,457.43. This represents a 36.39% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 577,292 shares of company stock worth $69,495,249. 12.50% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of research firms have issued reports on ALAB. Loop Capital started coverage on shares of Astera Labs in a research report on Thursday, March 5th. They issued a "buy" rating and a $250.00 target price for the company. Barclays set a $165.00 price target on shares of Astera Labs in a research note on Thursday, January 15th. Weiss Ratings cut Astera Labs from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Monday, February 23rd. Royal Bank Of Canada began coverage on Astera Labs in a research note on Wednesday, January 14th. They issued an "outperform" rating and a $225.00 target price on the stock. Finally, Northland Securities raised their price target on Astera Labs from $175.00 to $195.00 and gave the stock an "outperform" rating in a research note on Tuesday, December 9th. Fifteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $199.44.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.